I agree , with no growth forecast , management leaving, a number of problem divisions , and profit downgraded to 5-7c per share ,high debt levels a PE of 16-20 seems very high.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025
Week 48 Wrap: ASX flirts with 8,500pts; APRA declines mortgage loan easing; Trump's Bessent tied to Dem donor